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Abstract. Typhoid fever, caused by Salmonella enterica serovar Typhi (S. Typhi), is a diminishing public health
problem in Vietnam, and this process may represent a prototype for typhoid elimination in Asia. Here, we review typhoid
epidemiology in Vietnam over 20 years and assess the potential drivers associated with typhoid reduction. In the 1990s,
multidrug resistant S. Typhi were highly prevalent in a sentinel hospital in southern Vietnam. A national typhoid incidence
rate of 14.7/100,000 population per year was estimated around the new millennium. The Vietnamese government rec-
ognized the public health issue of typhoid in the 1990s and initiated vaccine campaigns to protect the most vulnerable
members of the population. At their peak, these campaigns immunized approximately 1,200,000 children in 35 provinces.
Concurrently, Vietnam experienced unprecedented economic development from 1998 to 2014, with the gross national
income per capita increasing from $360 to $1,890 over this period. More recent typhoid incidence data are not available,
but surveillance suggests that the current disease burden is negligible. This trajectory can be considered a major public
health success. However, a paucity of systematic data makes it difﬁcult to disaggregate the roles of immunization and
water, sanitation, and hygiene (WASH) interventions in typhoid reduction in Vietnam. Given the limitations of typhoid
vaccines, we surmise the practical elimination of typhoid was largely driven by economic development and improvement
in general population living standards. Better designedWASH intervention studieswith clinical endpoints and systematic
incidence data are essential to glean a greater understanding of contextual factors that impact typhoid incidence
reduction.
INTRODUCTION
Typhoid fever, the disease caused by Salmonella enterica
serovar Typhi (S. Typhi), is a diminishing public health problem
in Vietnam.1 However, the disease remains an ongoing public
health issue in other parts of South andSoutheast Asia,2–4 and
an enhanced understanding of disease estimates and the in-
ﬂuence of antimicrobial resistance (AMR) on disease pre-
sentation is needed to better control this disease across the
region. Furthermore, insights into the trends of typhoid and
factors that directly impinge on disease incidence are impor-
tant for allocating resources for reducing the burden of dis-
ease.5 Currently, Vietnam represents an exemplar Asian
country that has all but eliminated this once common in-
fection, and there is much to be learnt from the reduction of
typhoid in Vietnam. However, how reduction in typhoid was
precisely achieved is unclear, and providing a roadmap for
typhoid reduction in similar settings is largely dependent on
good historical quantitative data.
Typhoid fever incidence in Vietnam. Typhoid fever has
likely been endemic in Vietnam for some time, although his-
torical incidencedata for this commoncauseof febrile disease
from across Southeast Asia before the reuniﬁcation of Vietnam
in 1975 is scarce. Notiﬁed typhoid fever cases reported to the
pre-reuniﬁcation government of South Vietnam showed a
generally increasing trend from 2.05 cases per 100,000 people
annually in 1957 to 10.02 cases per 100,000 people annually in
1966 (Figure 1).6 Health care provisions, and water and sani-
tation infrastructure in South Vietnam during this time period
were generally poor, which likely contributed to the increasing
rates of typhoid fever and other infectious disease during this
period, which were frequently observed in military personnel
returning back to the United States.7 By contrast, a report
suggests that the pre-reuniﬁcation government in North Viet-
namprioritizedhealth careaccessandbeganmassvaccination
campaigns against typhoid fever and other communicable
diseases as early as 1954, although reliable incidence data
from North Vietnam during this period are not available.8
The best and most accurate recent estimates of typhoid
incidence in Vietnam were calculated during the In-
ternational Vaccine Institute’s Diseases of the Most Impov-
erished (DOMI) program, which was conducted between
1999 and 2003.9 The annual incidence of typhoid fever in
Hue, in central Vietnam, in 2002–2004 was estimated to be
21.3/100,000 person years and 24.2/100,000 person years
in children aged 5–15 in years (Figure 1). This program went
on to conduct various epidemiological investigations and
vaccine studies in the same location.10,11 In addition, the
National Institute of Epidemiology (NIHE) in Hanoi con-
ducted further nationwide surveillance around the same
period of time as the DOMI study. The average number of
typhoid cases in Vietnam across the country in all ages was
estimated to be 11,696, corresponding with an average
national incidence rate of 14.7/100,000 population per
year.12 During this period (1999–2003) two of the 63 prov-
inces of Vietnam (Soc Trang in the south and Dien Bien in the
north) were estimated to have particularly high inci-
dences (> 100/100,000 population per year) (Figure 2); a
further 18 were estimated to have a medium incidence
(> 10 < 100/100,000 population per year). The propensity of
the disease was understood to arise in children, with an
estimated incidence of 36.6/100,000 population aged < 15
years per year.12 Lastly, in 1998, Lin and others.13 estimated
a population incidence of 198/100,000 population in the
Dong Thap province in the Mekong Delta, equating with a
crude incidence of 930/100,000 people (Figure 1).
Typhoid trends in Ho Chi Minh City (HCMC). Routine
blood culture data from the Hospital for Tropical Diseases
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(HTD) in HCMC in the south of Vietnam between 1994 and
2015 highlights a major reduction in the prevalence (and ab-
solute number) of positive blood cultures forS. Typhi over time
(Figure 3).1 Hospital for Tropical Diseases is a sentinel in-
fectious disease hospital that serves as a primary and sec-
ondary facility for the surrounding local population in HCMC
anda tertiary referral center for 17 provinces in the south of the
country, and, therefore, has a catchment population of ap-
proximately 40 million people. The highest rates of positive
blood cultures for S. Typhi at HTD were recorded in 1995 and
1998, when the proportion of positive blood cultures for S.
Typhi was 14.5% and 12.8% (of all blood cultures taken), re-
spectively. In the late 1990s, this ﬁgure began to show an
annual decline; 5% S. Typhi blood culture positivity rate of all
blood cultures taken in 1999. After the turn of the millennium,
the number of culture positive cases of typhoid fever at HTD
continued to decrease annually, with the prevalence of S.
Typhi–positive blood cultures not rising higher than 1% from
2005 onward. Therefore, in the absence of contemporary (and
accurate incidence) data, if we extrapolate these trends we
FIGURE 1. Historic crude estimates of typhoid fever incidence in Vietnam. Histogram showing the estimated crude incidences (on a log scale) of
typhoid fever in Vietnam from government records (GR) and subnational incidence estimates available from Ochiai et al.9 (aggregated estimated
from 2002 to 2004, with 2003 as the midpoint from Hue province in people aged 5–18 years) and Lin et al.13 (aggregated estimated from 1997 to
2000, with 1998 as the midpoint from Dong Thap province).
FIGURE 2. Map of Vietnam showing estimated disease incidences and provinces implemented Vi immunization. (A) North orientated map of
Vietnamshowing the estimated incidenceof typhoid fever in Vietnam fromgovernment data between1999 and 2003. Provinceswith high,medium,
and low incidence are highlighted by shading (see key). (B) North orientatedmap of Vietnam showing the 35 provinces in Vietnam in 2005 that were
incorporated into the national typhoid Vi immunization campaign; blue shading (see key). Maps are reproduced from Cuong N. Typhoid Vaccine
Used in Vietnam and its Impact. In: Consultation on Typhoid Vaccine Introduction and Typhoid Surveillance.12
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can surmise that presently the incidence of enteric fever in
Vietnam isprobablyexceptionally low (<10/100,000population
per year), and there has been a remarkable and sustained de-
cline in the prevalence of S. Typhi–positive blood cultures in
HTD and other health care facilities across the country.
In a pattern similar to those observed in parts of sub-
SaharanAfrica (but not in the samemagnitude), therehasbeen
a replacement of “classical” community-acquired pathogens
in bloodstream infections (such as S. Typhi) with those more
commonly associated with HIV infection and the current in-
ternational epidemic of AMRbacteria.14 Speciﬁcally, assorted
fungal pathogens, multidrug-resistant (MDR) non-Salmonella
Gram-negative bacteria, and non-typhoidal Salmonella
now dominate the bloodstream infection landscape in
Vietnam.1,15,16 Paratyphoid fever, which is associatedwith the
various pathovars of Salmonella Paratyphi (S. Paratyphi A, B,
and C), has been reported to be increasing in prevalence in
parts of Asia.17 This surge is speciﬁcally associated with S.
Paratyphi A; however, the isolation of this organism is rare in
Vietnam (andacrossSoutheastAsia) and is generally limited to
extended sporadic outbreaks, as recently observed in neigh-
boring Cambodia.18 A study conducted at HTD cultured less
than 7 S. Paratyphi A isolates per year between 1998 and
2008, this subsequently declined to zero from 2008.1
However, in 1990, Global Burden of Disease estimated in-
cidence of paratyphoid to be 81/100,000 population; this was
estimated to be 40/100,000 population in 2016.19
Antimicrobial susceptibility. Traditionally, Vietnam has
been a global hotspot for multi-drug resistant (MDR) S. Typhi,
which is deﬁned as resistance against the ﬁrst-line antimicro-
bials, ampicillin, chloramphenicol, and trimethoprim-sulphate.20
These latter day ﬁrst-line regimes were commonly prescribed
in the community and in health care settings for the treatment
of typhoid fever, and many non-speciﬁc febrile diseases, in
Vietnam in the 1980s and early 1990s. The ﬁrst notable spike
of MDR S. Typhi in Vietnam arose in the early 1990s, corre-
lating with a major peak in S. Typhi–positive blood cultures at
HTD in HCMC.21 This MDR phenotype in S. Typhi was asso-
ciated with an incH1 plasmid backbone,22 which has been
consistently identiﬁed within S. Typhi isolated in Vietnam and
coupled with organisms belonging to a speciﬁc phylogenetic
group known as haplotype 58,23 now designated genotype
4.3.1.24 These organisms, with this same MDR phenotype,
were described as still circulating in high numbers in the
MekongDelta region, some150 kmaway fromHCMC, in 2004
and 2005.25
Salmonella enterica serovar Typhi belonging to genotype
4.3.1 are also commonly associatedwith amutation (S83F) in
FIGURE 3. The decline in Salmonella Typhi–positive blood cultures in a sentinel infectious disease hospital in Ho Chi Minh City (HCMC). Plot
showing the proportion of total blood cultures taken fromwhich Salmonella Typhi was isolated between 1993 and 2015 at the Hospital for Tropical
Diseases in HCMC, with a locally weighted scatterplot smoothing curve. The total number of blood cultures taken and the number from which
Salmonella Typhi were isolated are shown at the base of the ﬁgure.
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the DNA gyrase gene gyrA, catalyzing resistance against
naladixic acid and reduced susceptibility against the
second-generation ﬂuoroquinolones, ciproﬂoxacin, and
oﬂoxacin.26,27 Variants with this speciﬁc gyrAmutation began
to emerge in Vietnam in the early 1990s,28 shortly after the
introduction of quinolones for the treatment of non-speciﬁc
febrile diseases when the ﬁrst-line treatments became less
effective at inducing defervescence. The secondary peak in
S. Typhi cases in routine blood culture data from HTD was
associated with the emergence of organisms exhibiting re-
sistance against quinolones and reduced susceptibility
against ﬂuoroquinolones.1,29 These organisms, speciﬁcally
genotype 4.3.1 S. Typhi with an S83F mutation in gyrA, have
since become themost prevalent variant in Vietnam,25 reﬂecting
the pattern of the molecular epidemiology of S. Typhi across
much of Asia.27 Current information regarding the AMR proﬁles
of the extant S. Typhi population in Vietnam are limited, but our
unpublished data suggests that MDR strains have all but dis-
appeared in the southern part of the country and S. Typhi with
an S83F and reduced susceptibility to ﬂuoroquinolones con-
tinue to circulate. Notably, despite the sustained use and
availability of ﬂuoroquinolones in Vietnam for various bacterial
infections, ciproﬂoxacin- and oﬂoxacin-resistant S. Typhi has
yet toemerge,although ithasbeenobservedelsewhere inAsia.30
Vaccination campaigns. The Vietnamese government
recognized the public health issue of typhoid fever in the
1990s and initiated several vaccine campaigns with in-
ternationally manufactured vaccines in an attempt to protect
the most vulnerable groups within the population, most
commonly children.31 Furthermore, NIHE in Hanoi was a pi-
oneer in instigating locally manufactured Vi Polysaccharide
vaccine and distributing it as a control measure through the
public health network. However, despite a Vi conjugate vac-
cine and a neworal attenuated typhoid vaccine being trialed in
Vietnam for the ﬁrst time, these were never introduced as
public health interventions.32,33 All the national typhoid Vi
Polysaccharide vaccine programs conducted between 1997
and 2012 were executed as school-based campaigns, im-
munizing children between the ages of 3 and 10 years.
Between 1997 and 2003, the Vietnamese government im-
munized more than 4,000,000 children aged 3–5 years with
TYPHIMVi polysaccharide,manufactured byAventis Pasteur.
After manufacturing their own Vi polysaccharide vaccine
through the Institute of Vaccines and Medical Biologicals/Da
Lat Pasteur Vaccine Company, the Vietnamese public health
systemadministeredmore than 2,000,000 additional doses to
children aged 5–10 years (2004–2010), and latterly children
aged 3–5 years (2011–2012). At the peak of these Vi vaccine
campaigns in 2005 (1,200,000 doses), children were being
immunized in 35 different provinces across the country
(Figure 2).12 The coverage rate of these campaigns were high,
with > 90% of the target population receiving a Vi vaccine
between1999 and2010. Population baseddata assessing the
direct effect (i.e., without additional sanitation covariates) of
these immunization programs on typhoid incidence are un-
available, but there was a substantial decrease in the in-
cidenceof typhoid fever across the country between 1997 and
2007, most notably in the northwest of the country and the
Mekong River Delta in the South, which were covered exten-
sively by the immunization program (Figure 2).12
Contextual factors that may have inﬂuenced typhoid
fever incidence. Being of low socioeconomic status is a
major risk factor for contracting typhoid fever.34 Vietnam
has been through an unprecedented period of economic
development since the mid-1990s, which has had a sub-
stantial knock-on effect on the reduction of poverty and
poverty-associated communicable diseases.35 Between
1998 and 2014 Vietnam’s gross domestic product in-
creased from $27 billion to $86 billion, and the gross na-
tional income per capita increased from $360 to $1,890 over
the same time period.36 These ﬁgures correlate with a re-
duction in national poverty (poverty headcount ratio at $1.90
adaydeclining from34.8% in1998 to 3.2% in 2012) (Figure 4)
and a waning in typhoid fever incidence, but overlap with the
period of the national immunization campaigns. In addition,
multiple contextual factors are considered to have had an
effect on the incidence of typhoid fever. Typhoid fever is
associated with poor water quality, and evidence of the or-
ganism in water supplies can be measured using molecular
methods.37 Consequently, water, sanitation, and hygiene
(WASH) conditions are one of the major factors in assessing
disease control. Sub-national data on water and sanitation
extracted from Multiple Indicator Cluster Surveys (MICS) in
Vietnam show that the fraction of the population in the
southeast of Vietnam with access to improved sanitation
facilities (means of excreta disposal that decrease human
contact with feces) increased from only 42% in 1995 to
93.6% in 2014.38 Furthermore, the proportion of the south-
eastern population of Vietnam with improved water sources
(as per MICS standards; water piped into homes or yard,
public taps, standpipes, protected wells, or springs) rose
from 93.6% in 2006 to a peak of 98.4% in 2011.38 Corre-
spondingly, data from theWorldBank shows that there was a
steady increase in the proportion of the Vietnamese pop-
ulation with access to improved sources of drinking water
between 1998 (74.5% of the population) and 2014 (96.4% of
the population).39 Similarly, there was an increase in the
proportion of the population with access to improved sani-
tation facilities, including ﬂush and slab latrines, over the
sameperiod; 49.5%of the population in 1998 to 76.3%of the
population in 2012 (urban/rural data shown in Figure 4).39
Knowledgegaps.All available data suggest that the trend
of typhoid fever incidence began to exhibit a steep decline in
Vietnam from 1999 onward. Therefore, the outstanding
questions regarding the dramatic reduction in typhoid fever
in Vietnam are: towhat extent did immunization play a role in
reducing typhoid fever? and how much inﬂuence did eco-
nomic growth have on improving living standards to reduce
all waterborne diseases, including typhoid fever? Given the
paucity of data regarding the longitudinal incidences of ty-
phoid fever (and other waterborne diseases) in Vietnam,
disaggregating the independent effect of these differing
approaches is a major challenge. Furthermore, dissimilar
demographics, disease epidemiology, and disease in-
cidence across the provinces of Vietnammake it impractical
to assess the overall impact of a speciﬁc intervention in any
given location. The data that are available are inconclusive
and limited by disease time trends from a single tertiary
referral hospital in HCMC. As a result, these data do not
provide insight into regional differences in typhoid fever
reduction across Vietnam or characterize the current na-
tional burden. Furthermore, there are no systematic data
regarding intestinal perforation (although this has been
described in the southern provinces of Vietnam40), other
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severe disease presentations,41 or typhoid-associated mor-
tality. As a result, it is impossible to directly assess any trends
associated with these severe outcomes.
Regardless of the precise role of any single intervention,
the reduction and virtual elimination of typhoid fever in
Vietnam, largely driven by strong political will,as evidenced
by sanitation improvements, better health care, and im-
munization campaigns, should be considered a major
public health success. However, this success story does
not quite replicate into a blueprint in how typhoid fever
should be controlled across Asia, that is, what worked in
Vietnam may not work in precisely the same way in other
locations. It is likely that the various vaccination campaigns
that have taken place in Vietnam over the last 15 years have
contributed to the observed decreasing trend in typhoid
fever, but their effect is difﬁcult to assess. However, the
immunization campaigns were conducted in children in
selected provinces, and these individuals received a single
dose of the Vi polysaccharide vaccine. This vaccine only
provides limited efﬁcacy in the ﬁrst year after immunization
and there is a rapid decline in antibody titer 2 years after
receiving the vaccine,42,43 herd protection remains variable.
Therefore, weconclude that economicdevelopment, improved
access to clean water supplies, better sanitation, and a re-
duction in poverty probably played the greatest combined role
in reducing the incidence of typhoid in Vietnam. Quantifying
the precise contribution of these in the reduction of typhoid
incidence isagainproblematic, and therearemultipleadditional
factors that shouldalsobeconsidered thatmayconfound these
interactions. It is, however, worth stating that S. Typhi appears
tobeprofoundly sensitive to improvements in sanitation, which
reduces human exposure to the organism, thus, lessening
disease incidence and person-to-person transmission.
CONCLUSION
The reduction of typhoid fever in Vietnam has been re-
markable, and has been largely driven by economic devel-
opment and improved living standards for the population.
Immunization has probably had some impact on disease re-
duction, but the use of an imperfect vaccine may only provide
limited respite in disease transmission without required im-
provements in WASH. Better designed WASH intervention
studieswith disease endpoints and systematic incidence data
are required to glean a greater understanding of the precise
contextual factors that impact on typhoid fever incidence.
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